Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Pastores

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Bailliere'S Clinical Haematology|March 14, 1998
Gaucher's Disease. Pathological featuresG M Pastores
International Journal of Clinical Pharmacology and Therapeutics|December 31, 2009
Krabbe disease: an overviewG M Pastores
Lancet (London, England)|September 1, 2001
Enzyme-replacement therapy for Anderson-Fabry diseaseG M Pastores, R Thadhani
Lancet (London, England)|August 26, 1998
Pulmonary hypertension in Gaucher's diseaseG M Pastores, A Miller
Medicina Clinica|June 4, 1994
[Treatment of Gaucher's disease type I. Towards a definitive solution?]J I Pérez Calvo, G M Pastores
Drugs of Today (Barcelona, Spain : 1998)|May 28, 2003
Gaucher disease: Genetics, diagnosis and managementM. Levin, I. Pleskova, G. M. Pastores
Genetics and Molecular Research : GMR|December 1, 2007
Laronidase for treating mucopolysaccharidosis type IR P El Dib, G M Pastores
Journal of Inherited Metabolic Disease|May 22, 2007
Very long chain acyl-CoA dehydrogenase deficiency in a pair of mildly affected monozygotic twin sister in their late fiftiesA Zia, E H Kolodny, G M Pastores
Current Rheumatology Reports|December 21, 2000
Bone and joint complications related to Gaucher diseaseG M Pastores, M J Patel, H Firooznia
Blood|July 15, 1993
Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 monthsG M Pastores, A R Sibille, G A Grabowski
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Bailliere'S Clinical Haematology|March 14, 1998
Gaucher's Disease. Pathological featuresG M Pastores
International Journal of Clinical Pharmacology and Therapeutics|December 31, 2009
Krabbe disease: an overviewG M Pastores
Lancet (London, England)|September 1, 2001
Enzyme-replacement therapy for Anderson-Fabry diseaseG M Pastores, R Thadhani
Lancet (London, England)|August 26, 1998
Pulmonary hypertension in Gaucher's diseaseG M Pastores, A Miller
Medicina Clinica|June 4, 1994
[Treatment of Gaucher's disease type I. Towards a definitive solution?]J I Pérez Calvo, G M Pastores
Drugs of Today (Barcelona, Spain : 1998)|May 28, 2003
Gaucher disease: Genetics, diagnosis and managementM. Levin, I. Pleskova, G. M. Pastores
Genetics and Molecular Research : GMR|December 1, 2007
Laronidase for treating mucopolysaccharidosis type IR P El Dib, G M Pastores
Journal of Inherited Metabolic Disease|May 22, 2007
Very long chain acyl-CoA dehydrogenase deficiency in a pair of mildly affected monozygotic twin sister in their late fiftiesA Zia, E H Kolodny, G M Pastores
Current Rheumatology Reports|December 21, 2000
Bone and joint complications related to Gaucher diseaseG M Pastores, M J Patel, H Firooznia
Blood|July 15, 1993
Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 monthsG M Pastores, A R Sibille, G A Grabowski
Pageof 7